XML 40 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Cash Flows (USD $)
In Thousands
12 Months Ended
May 31, 2011
May 31, 2010
May 31, 2009
Cash Flows From Operating Activities:      
Net Income $ 203,168 $ 181,127 $ 119,616
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 52,385 61,823 62,379
Amortization 20,368 22,430 22,765
Net loss upon deconsolidation of SPHC   7,946  
Goodwill and other intangible asset impairments     15,462
Other-than-temporary impairments on marketable securities 693 260 15,062
Deferred income taxes cash flow 7,708 32,485 2,468
Stock-based compensation expense 12,282 10,030 8,008
Other (1,086) (1,768) (1,316)
Changes in assets and liabilities, net of effect from purchases and sales of businesses:      
Decrease (increase) in receivables (70,440) (17,748) 181,617
Decrease (increase) in inventory (71,523) (15,059) 75,014
Decrease (increase) in prepaid expenses and other current and long-term assets (22,645) 2,230 18,024
(Decrease) increase in accounts payable 55,896 19,638 (119,327)
(Decrease) increase in accrued compensation and benefits 19,564 7,206 (29,039)
(Decrease) increase in accrued loss reserves (8,198) (2,705) 5,167
(Decrease) increase in other accrued liabilities 28,235 42,079 (14,040)
Payments made for asbestos-related claims   (92,621) (69,417)
Other 11,759 (53,417) (25,448)
Cash From (Used For) Operating Activities 238,166 203,936 266,995
Cash Flows From Investing Activities:      
Capital expenditures (39,826) (23,241) (54,986)
Acquisition of businesses, net of cash acquired (38,972) (73,985) (16,669)
Purchase of marketable securities (92,060) (105,364) (75,410)
Proceeds from sales of marketable securities 77,035 93,972 65,862
Proceeds from sales of assets and businesses 1,301 1,892 852
Decrease in cash due to deconsolidation of SPHC   (18,568)  
Other (13,418) (1,659) (1,196)
Cash (Used For) Investing Activities (105,940) (126,953) (81,547)
Cash Flows From Financing Activities:      
Additions to long-term and short-term debt 200,499 314,059 56,816
Reductions of long-term and short-term debt (24,502) (319,642) (51,412)
Cash dividends (108,585) (105,430) (101,836)
Repurchase of stock (21,811)   (45,360)
Exercise of stock options 12,116 14,667 3,188
Proceeds From Payments For Other Financing Activities 0 (2,283) 0
Cash (Used For) Financing Activities 57,717 (98,629) (138,604)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 29,713 (16,386) (24,708)
Net Change in Cash and Cash Equivalents 219,656 (38,032) 22,136
Cash and Cash Equivalents at Beginning of Period 215,355 253,387 231,251
Cash and Cash Equivalents at End of Period 435,011 215,355 253,387
Supplemental Cash Flow Information [Abstract]      
Interest Paid 62,892 53,897 51,316
Income Taxes Paid 67,380 45,090 62,930
Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]      
Debt from business combinations 0 2,991 20
Issuance of stock for convertible-bond redemption     $ 150,612